Clinical Trial Update: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of the bispecific antibody MCLA-158 in patients with advanced solid tumors. Recruitment is ongoing across…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• MCLA-158

Snippet

Sponsor: Merus B.V. | Conditions: Advanced/Metastatic Solid Tumors, Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING